Kezar Life Sciences, Inc.
USD7.29
+0.00 (+0.00%)
CEO
Christopher J. Kirk
IPO Date
2018-06-21
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$7.29
Prev. Close
$7.29
Day Low
$7.29
Day High
$7.29
52W Low
$3.53
52W High
$7.55
Market Cap
$0.05B
| -5.9 |
| 31 Dec 2023 | FY | 100.0% | -1455.3% | -54.3% | -46.0% | 0.10 | 11.66 | -67.4 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -25.3% | -22.8% | 0.08 | 25.98 | -695.0 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -27.7% | -25.1% | 0.07 | 25.77 | -1614.7 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -29.6% | -27.5% | 0.04 | 22.48 | -550.3 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -45.0% | -39.2% | 0.08 | 13.52 | -218.1 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -21.3% | -20.2% | 0.00 | 32.91 | -1937.9 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | 33.2% | -15.7% | 0.00 | 35.26 | -2713.6 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | 51.6% | -78.7% | 0.00 | 16.11 | -2570.8 |
| -0.8 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -13.5% | -11.5% | 0.12 | 7.06 | -0.6 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -14.9% | -12.6% | 0.13 | 7.29 | -0.6 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -16.1% | -13.2% | 0.14 | 7.09 | -0.5 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -17.3% | -14.0% | 0.14 | 6.76 | -0.6 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -15.2% | -12.4% | 0.13 | 7.65 | -69.4 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -14.3% | -12.0% | 0.12 | 9.58 | -49.4 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -12.8% | -10.9% | 0.11 | 11.49 | -77.3 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -17.2% | -14.6% | 0.10 | 11.66 | -53.4 |